Mylan Pharmaceuticals Inc v. Sanofi Aventis Deutschland GmbH

Richard Torczon

Mylan targets Sanofi's insulin stability patent: LANTUS label & Lougheed prior art cited for obviousness against all 25 claims on aggregation.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Erica A Franklin	400+	56%	68%
Michelle N Ankenbrand	200+	50%	80%
Roberta Pollock	400+	70%	70%

Name	Ratings
Weil, Gotshal & Manges LLP	L5A
Anish Desai	L2D
Elizabeth Weiswasser	L2E
Buchanan Ingersoll & Rooney PC	L5A
Aaron L. Joseph Pereira	L3D